Anticancer Agents: Towards the Future
A major need in cancer chemotherapy is the availability of cancer cell-specific drugs. This paper discusses recent advances and perspectives in the field of selective drug recognition considering the key targets tyrosine kinases, DNA-topoisomerases and telomerase.
Keywords: drug-specificity, tyrosine kinase, topoisomerase, telomerase
Rights & PermissionsPrintExport